Extendicare Stock Net Income
| EXE Stock | CAD 24.21 0.32 1.34% |
As of the 6th of February, Extendicare shows the Downside Deviation of 1.38, mean deviation of 1.51, and Coefficient Of Variation of 389.64. Extendicare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Extendicare Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.5273 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 86.5 M | 90.8 M | |
| Net Income From Continuing Ops | 86.5 M | 90.8 M | |
| Net Income Applicable To Common Shares | 86.5 M | 51.4 M | |
| Net Income Per Share | 0.80 | 0.84 | |
| Net Income Per E B T | 0.87 | 0.91 |
Extendicare | Net Income |
Evaluating Extendicare's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Extendicare's fundamental strength.
Latest Extendicare's Net Income Growth Pattern
Below is the plot of the Net Income of Extendicare over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Extendicare financial statement analysis. It represents the amount of money remaining after all of Extendicare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Extendicare's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Extendicare's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 75.21 M | 10 Years Trend |
|
Net Income |
| Timeline |
Extendicare Net Income Regression Statistics
| Arithmetic Mean | 49,170,307 | |
| Geometric Mean | 34,923,702 | |
| Coefficient Of Variation | 120.09 | |
| Mean Deviation | 40,348,325 | |
| Median | 35,452,000 | |
| Standard Deviation | 59,050,046 | |
| Sample Variance | 3486.9T | |
| Range | 262.5M | |
| R-Value | 0.21 | |
| Mean Square Error | 3557.2T | |
| R-Squared | 0.04 | |
| Significance | 0.42 | |
| Slope | 2,442,055 | |
| Total Sum of Squares | 55790.5T |
Extendicare Net Income History
Extendicare Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Extendicare is extremely important. It helps to project a fair market value of Extendicare Stock properly, considering its historical fundamentals such as Net Income. Since Extendicare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Extendicare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Extendicare's interrelated accounts and indicators.
Click cells to compare fundamentals
Extendicare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Extendicare's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Extendicare.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Extendicare on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Extendicare or generate 0.0% return on investment in Extendicare over 90 days. Extendicare is related to or competes with WELL Health, Sienna Senior, Cronos, Medical Facilities, Nova Leap, CareRx Corp, and Tilray. Extendicare Inc. provides care and services for seniors in Canada More
Extendicare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Extendicare's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Extendicare upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.38 | |||
| Information Ratio | 0.2385 | |||
| Maximum Drawdown | 18.92 | |||
| Value At Risk | (2.21) | |||
| Potential Upside | 3.02 |
Extendicare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Extendicare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Extendicare's standard deviation. In reality, there are many statistical measures that can use Extendicare historical prices to predict the future Extendicare's volatility.| Risk Adjusted Performance | 0.1999 | |||
| Jensen Alpha | 0.6163 | |||
| Total Risk Alpha | 0.5115 | |||
| Sortino Ratio | 0.4277 | |||
| Treynor Ratio | 1.98 |
Extendicare February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1999 | |||
| Market Risk Adjusted Performance | 1.99 | |||
| Mean Deviation | 1.51 | |||
| Semi Deviation | 0.8708 | |||
| Downside Deviation | 1.38 | |||
| Coefficient Of Variation | 389.64 | |||
| Standard Deviation | 2.48 | |||
| Variance | 6.17 | |||
| Information Ratio | 0.2385 | |||
| Jensen Alpha | 0.6163 | |||
| Total Risk Alpha | 0.5115 | |||
| Sortino Ratio | 0.4277 | |||
| Treynor Ratio | 1.98 | |||
| Maximum Drawdown | 18.92 | |||
| Value At Risk | (2.21) | |||
| Potential Upside | 3.02 | |||
| Downside Variance | 1.92 | |||
| Semi Variance | 0.7583 | |||
| Expected Short fall | (1.92) | |||
| Skewness | 3.45 | |||
| Kurtosis | 20.02 |
Extendicare Backtested Returns
Extendicare appears to be very steady, given 3 months investment horizon. Extendicare secures Sharpe Ratio (or Efficiency) of 0.28, which denotes the company had a 0.28 % return per unit of risk over the last 3 months. By reviewing Extendicare's technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please utilize Extendicare's Coefficient Of Variation of 389.64, downside deviation of 1.38, and Mean Deviation of 1.51 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Extendicare holds a performance score of 22. The firm shows a Beta (market volatility) of 0.32, which means possible diversification benefits within a given portfolio. As returns on the market increase, Extendicare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Extendicare is expected to be smaller as well. Please check Extendicare's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Extendicare's price patterns will revert.
Auto-correlation | 0.70 |
Good predictability
Extendicare has good predictability. Overlapping area represents the amount of predictability between Extendicare time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Extendicare price movement. The serial correlation of 0.7 indicates that around 70.0% of current Extendicare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.7 | |
| Spearman Rank Test | 0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 0.79 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Extendicare Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Extendicare reported net income of 75.21 M. This is 77.96% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all Canada stocks is 86.83% higher than that of the company.
Extendicare Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Extendicare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Extendicare could also be used in its relative valuation, which is a method of valuing Extendicare by comparing valuation metrics of similar companies.Extendicare is currently under evaluation in net income category among its peers.
Extendicare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Extendicare from analyzing Extendicare's financial statements. These drivers represent accounts that assess Extendicare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Extendicare's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 656.9M | 583.9M | 618.7M | 895.2M | 1.0B | 864.6M | |
| Enterprise Value | 1.1B | 800.6M | 878.0M | 1.1B | 1.2B | 1.6B |
Extendicare Fundamentals
| Return On Equity | 0.66 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 2.43 B | ||||
| Shares Outstanding | 94.46 M | ||||
| Shares Owned By Insiders | 0.47 % | ||||
| Shares Owned By Institutions | 34.96 % | ||||
| Number Of Shares Shorted | 1.96 M | ||||
| Price To Earning | 26.74 X | ||||
| Price To Book | 13.77 X | ||||
| Price To Sales | 1.44 X | ||||
| Revenue | 1.47 B | ||||
| Gross Profit | 227.52 M | ||||
| EBITDA | 155.27 M | ||||
| Net Income | 75.21 M | ||||
| Cash And Equivalents | 121.85 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 292.49 M | ||||
| Debt To Equity | 6.07 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | 1.96 X | ||||
| Cash Flow From Operations | 143.64 M | ||||
| Short Ratio | 8.64 X | ||||
| Earnings Per Share | 1.06 X | ||||
| Target Price | 26.15 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 2.29 B | ||||
| Total Asset | 719.79 M | ||||
| Retained Earnings | (352.55 M) | ||||
| Working Capital | (49.18 M) | ||||
| Current Asset | 211.37 M | ||||
| Current Liabilities | 218.02 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 5.98 % | ||||
| Net Asset | 719.79 M | ||||
| Last Dividend Paid | 0.49 |
About Extendicare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Extendicare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Extendicare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Extendicare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving against Extendicare Stock
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.